Danaher Corporation logo
Danaher Corporation (DHR)
Compare

Danaher Corporation (DHR) EV/Sales Ratio: 5.69x

Is Danaher Corporation’s EV/Sales ratio high or low?

Danaher Corporation's EV/Sales ratio of 5.69x is 19% below its 5-year average of 6.99x, near the low end of its 5-year range (5.16x–9.52x).

As of Monday, June 15, 2026. 14.05% below its 12-month average of 6.62x.

DHR EV/Sales Ratio Chart

DHR EV/Sales Ratio
5.69x-17.06% 1Y
Zoom

DHR Average EV/Sales Ratio Chart

DHR Current vs Average EV/Sales Ratio Chart

DHR EV/Sales Ratio Metrics

EV/SALES RATIO

5.69x

EV/SALES RATIO AVG TTM

6.62x

EV/SALES RATIO AVG 3Y

7.16x

EV/SALES RATIO AVG 5Y

6.99x

EV/SALES RATIO AVG 10Y

5.91x

EV/SALES RATIO AVG 15Y

4.61x

EV/SALES RATIO AVG 20Y

3.87x

CURRENT VS TTM AVG

-14.05%

CURRENT VS 3Y AVG

-20.52%

CURRENT VS 5Y AVG

-18.65%

CURRENT VS 10Y AVG

-3.79%

CURRENT VS 15Y AVG

+23.55%

CURRENT VS 20Y AVG

+46.92%

DHR Competitors' EV/Sales Ratio

NAMEMARKET CAPEV/SALES RATIOTTM3Y5Y
Danaher Corporation (DHR)$127.47B5.69x6.62x7.16x6.99x
CVS Health Corporation (CVS)vs ›$130.09B0.49x0.44x0.43x0.51x
Bristol-Myers Squibb Company (BMY)vs ›$116.66B3.13x2.99x3.12x3.47x
Vertex Pharmaceuticals Incorporated (VRTX)vs ›$112.92B9.02x9.43x10.00x9.07x
Intuitive Surgical, Inc. (ISRG)vs ›$145.58B13.78x18.37x19.51x18.68x
Pfizer Inc. (PFE)vs ›$149.38B3.36x3.30x3.43x3.63x
Medtronic plc (MDT)vs ›$102.97B3.44x4.21x4.19x4.55x
Abbott Laboratories (ABT)vs ›$153.59B4.02x4.93x5.00x4.98x
Gilead Sciences, Inc. (GILD)vs ›$155.93B5.79x6.02x4.98x4.64x
Elevance Health Inc. (ELV)vs ›$87.75B0.56x0.51x0.67x0.76x

Understanding EV/Sales

Enterprise Value (EV) = Market Cap + Total Debt - Cash

Sales = Total Revenue (TTM)

EV/Sales is commonly used because:

  • It works for unprofitable companies where P/E doesn't apply
  • Revenue is harder to manipulate than earnings
  • It supports comparisons across companies at different profitability stages
  • It is frequently used for software and other revenue-growth-focused companies

Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.

Danaher Corporation EV/Sales Ratio Formula & Definition

EV/Sales = Enterprise Value / Revenue (TTM)

Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Danaher Corporation EV/Sales Ratio FAQ

What is the EV/Sales ratio for Danaher Corporation (DHR)?
The EV/Sales ratio for DHR stock is 5.69x.
Is Danaher Corporation's EV/Sales ratio high or low?
Danaher Corporation's EV/Sales ratio of 5.69x is 19% below its 5-year average of 6.99x, near the low end of its 5-year range (5.16x–9.52x).
What is the TTM average EV/Sales ratio for Danaher Corporation (DHR)?
The TTM average EV/Sales ratio for DHR stock is 6.62x.
What is the 3Y average EV/Sales ratio for Danaher Corporation (DHR)?
The 3Y average EV/Sales ratio for DHR stock is 7.16x.
What is the 5Y average EV/Sales ratio for Danaher Corporation (DHR)?
The 5Y average EV/Sales ratio for DHR stock is 6.99x.
What is the 10Y average EV/Sales ratio for Danaher Corporation (DHR)?
The 10Y average EV/Sales ratio for DHR stock is 5.91x.
What is the 15Y average EV/Sales ratio for Danaher Corporation (DHR)?
The 15Y average EV/Sales ratio for DHR stock is 4.61x.
What is the 20Y average EV/Sales ratio for Danaher Corporation (DHR)?
The 20Y average EV/Sales ratio for DHR stock is 3.87x.

Danaher Corporation EV/Sales Ratio History

DATEEV/SALES RATIO
2026-06-125.69x
2026-06-115.71x
2026-06-105.79x
2026-06-095.92x
2026-06-085.78x
2026-06-055.81x
2026-06-045.87x
2026-06-035.63x
2026-06-025.57x
2026-06-015.68x
2026-05-295.76x
2026-05-285.70x
2026-05-275.49x
2026-05-265.48x
2026-05-225.45x
2026-05-215.49x
2026-05-205.43x
2026-05-195.31x
2026-05-185.22x
2026-05-155.16x
2026-05-145.24x
2026-05-135.28x
2026-05-125.29x
2026-05-115.30x
2026-05-085.43x
2026-05-075.56x
2026-05-065.54x
2026-05-055.53x
2026-05-045.51x
2026-05-015.54x
2026-04-305.65x
2026-04-295.65x
2026-04-285.65x
2026-04-275.70x
2026-04-245.60x
2026-04-235.64x
2026-04-225.80x
2026-04-216.10x
2026-04-206.13x
2026-04-176.20x
2026-04-166.17x
2026-04-156.30x
2026-04-146.31x
2026-04-136.23x
2026-04-106.05x
2026-04-096.15x
2026-04-086.24x
2026-04-076.09x
2026-04-066.12x
2026-04-026.09x
2026-04-016.08x
2026-03-316.05x
2026-03-305.88x
2026-03-275.82x
2026-03-266.00x
2026-03-255.98x
2026-03-246.06x
2026-03-236.06x
2026-03-206.04x
2026-03-196.06x
2026-03-186.10x
2026-03-176.21x
2026-03-166.10x
2026-03-135.98x
2026-03-125.95x
2026-03-116.21x
2026-03-106.21x
2026-03-096.32x
2026-03-066.22x
2026-03-056.41x
2026-03-046.49x
2026-03-036.47x
2026-03-026.52x
2026-02-276.66x
2026-02-266.62x
2026-02-256.63x
2026-02-246.62x
2026-02-236.83x
2026-02-206.79x
2026-02-196.84x
2026-02-186.77x
2026-02-176.70x
2026-02-136.88x
2026-02-126.95x
2026-02-117.10x
2026-02-107.09x
2026-02-097.00x
2026-02-067.00x
2026-02-056.98x
2026-02-047.09x
2026-02-037.00x
2026-02-027.20x
2026-01-307.07x
2026-01-297.09x
2026-01-287.24x
2026-01-277.56x
2026-01-267.59x
2026-01-237.54x
2026-01-227.69x
2026-01-217.75x
2026-01-207.52x
2026-01-167.57x
2026-01-157.69x
2026-01-147.63x
2026-01-137.56x
2026-01-127.66x
2026-01-097.64x
2026-01-087.54x
2026-01-077.56x
2026-01-067.59x
2026-01-057.55x
2026-01-027.41x
2025-12-317.36x
2025-12-307.42x
2025-12-297.41x
2025-12-267.41x
2025-12-247.44x
2025-12-237.42x
2025-12-227.34x
2025-12-197.24x
2025-12-187.23x
2025-12-177.18x
2025-12-167.24x
2025-12-157.35x
2025-12-127.29x
2025-12-117.47x
2025-12-107.41x
2025-12-097.20x
2025-12-087.23x
2025-12-057.29x
2025-12-047.31x
2025-12-037.35x
2025-12-027.30x
2025-12-017.22x
2025-11-287.30x
2025-11-267.35x
2025-11-257.42x
2025-11-247.31x
2025-11-217.32x
2025-11-207.17x
2025-11-197.17x
2025-11-187.26x
2025-11-177.11x
2025-11-147.14x
2025-11-137.14x
2025-11-127.08x
2025-11-116.98x
2025-11-106.84x
2025-11-076.81x
2025-11-066.83x
2025-11-056.87x
2025-11-046.92x
2025-11-036.93x
2025-10-316.97x
2025-10-306.96x
2025-10-296.93x
2025-10-287.01x
2025-10-277.13x
2025-10-247.19x
2025-10-237.18x
2025-10-227.05x
2025-10-217.12x
2025-10-206.76x
2025-10-176.91x
2025-10-166.97x
2025-10-156.82x
2025-10-146.82x
2025-10-136.79x
2025-10-106.71x
2025-10-096.77x
2025-10-086.79x
2025-10-076.90x
2025-10-066.99x
2025-10-037.09x
2025-10-026.95x
2025-10-017.02x
2025-09-306.59x
2025-09-296.22x
2025-09-266.18x
2025-09-256.08x
2025-09-246.22x
2025-09-236.33x
2025-09-226.35x
2025-09-196.44x
2025-09-186.50x
2025-09-176.43x
2025-09-166.35x
2025-09-156.30x
2025-09-126.34x
2025-09-116.49x
2025-09-106.42x
2025-09-096.47x
2025-09-086.60x
2025-09-056.65x
2025-09-046.61x
2025-09-036.62x
2025-09-026.75x
2025-08-296.81x
2025-08-286.80x
2025-08-276.79x
2025-08-266.83x
2025-08-256.87x
2025-08-226.99x
2025-08-216.76x
2025-08-206.98x
2025-08-197.00x
2025-08-186.91x
2025-08-156.97x
2025-08-146.94x
2025-08-136.91x
2025-08-126.81x
2025-08-116.63x
2025-08-086.66x
2025-08-076.59x
2025-08-066.49x
2025-08-056.61x
2025-08-046.56x
2025-08-016.55x
2025-07-316.55x
2025-07-306.76x
2025-07-296.84x
2025-07-286.73x
2025-07-256.80x
2025-07-246.72x
2025-07-236.58x
2025-07-226.34x
2025-07-216.28x
2025-07-186.41x
2025-07-176.55x
2025-07-166.50x
2025-07-156.49x
2025-07-146.64x
2025-07-116.85x
2025-07-106.87x
2025-07-096.74x
2025-07-086.73x
2025-07-076.70x
2025-07-036.80x
2025-07-026.78x
2025-07-016.74x
2025-06-306.63x
2025-06-276.67x
2025-06-266.75x
2025-06-256.74x
2025-06-246.63x
2025-06-236.60x
2025-06-206.60x
2025-06-186.54x
2025-06-176.58x
2025-06-166.74x
2025-06-136.73x
2025-06-126.86x
2025-06-116.85x
2025-06-106.79x
2025-06-096.68x
2025-06-066.59x
2025-06-056.47x
2025-06-046.50x
2025-06-036.47x
2025-06-026.38x

Showing the most recent 260 of 5,033 data points. The chart above shows the full history.

About Danaher Corporation

Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.

Washington, DC
61,000 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Rainer Blair